Evaluation of current therapies for COVID-19 treatment
A Sethi, H Bach - Microorganisms, 2020 - mdpi.com
The virus SARS-CoV-2, the etiological agent of COVID-19, is responsible for more than
400,000 deaths worldwide as of 10 June 2020. As a result of its recent appearance …
400,000 deaths worldwide as of 10 June 2020. As a result of its recent appearance …
Updated approaches against SARS-CoV-2
H Li, Y Zhou, M Zhang, H Wang… - Antimicrobial agents and …, 2020 - Am Soc Microbiol
Novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) lies behind the
ongoing outbreak of coronavirus disease 2019 (COVID-19). There is a growing …
ongoing outbreak of coronavirus disease 2019 (COVID-19). There is a growing …
Coronavirus disease 2019 treatment: a review of early and emerging options
EK McCreary, JM Pogue - Open forum infectious diseases, 2020 - academic.oup.com
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the cause of coronavirus
disease 2019 (COVID-19), has spread across the globe resulting in a pandemic. At the time …
disease 2019 (COVID-19), has spread across the globe resulting in a pandemic. At the time …
[HTML][HTML] An overview of the safety, clinical application and antiviral research of the COVID-19 therapeutics
D Wang, Z Li, Y Liu - Journal of infection and public health, 2020 - Elsevier
Since a novel coronavirus pneumonia outbreak in late December 2019, coronavirus disease-
19 (COVID-19) epidemic has gradually spread worldwide, becoming a major public health …
19 (COVID-19) epidemic has gradually spread worldwide, becoming a major public health …
COVID-19: Therapeutics and interventions currently under consideration
RB McFee - Disease-a-Month, 2020 - Elsevier
With the emergence of COVID-19 extensive research began to identify medications,
candidate compounds and other therapeutic approaches. The complex virology of COVID …
candidate compounds and other therapeutic approaches. The complex virology of COVID …
Emerging treatment strategies for COVID-19 infection
M Gavriatopoulou, I Ntanasis-Stathopoulos… - Clinical and …, 2021 - Springer
The new type of coronavirus (COVID-19), SARS-CoV-2 originated from Wuhan, China and
has led to a worldwide pandemic. COVID-19 is a novel emerging infectious disease caused …
has led to a worldwide pandemic. COVID-19 is a novel emerging infectious disease caused …
Emerging therapies for COVID-19 pneumonia
On 11 March 2020, the World Health Organization declared coronavirus disease 2019
(COVID-19) a pandemic. In recent months, with the spread of COVID-19, there has been …
(COVID-19) a pandemic. In recent months, with the spread of COVID-19, there has been …
Treatment options for COVID-19: a review
Background: The recent COVID-19 pandemic sweeping the globe has caused great concern
worldwide. Due to the limited evidence available on the dynamics of the virus and effective …
worldwide. Due to the limited evidence available on the dynamics of the virus and effective …
Therapeutic options against the new coronavirus: updated clinical and laboratory evidences
ACL Fernandes, AJM Vale, FP Guzen… - Frontiers in …, 2020 - frontiersin.org
The pandemic caused by the new coronavirus (SARS-Cov-2) has encouraged numerous in
vitro studies and clinical trials around the world, with research groups testing existing drugs …
vitro studies and clinical trials around the world, with research groups testing existing drugs …
[HTML][HTML] COVID-19 antiviral and treatment candidates: current status
E Españo, D Kim, J Kim, SK Park, JK Kim - Immune network, 2021 - ncbi.nlm.nih.gov
Abstract The coronavirus disease 2019 (COVID-19) pandemic caused by the severe acute
respiratory syndrome coronavirus 2 has severely impacted global health and economy …
respiratory syndrome coronavirus 2 has severely impacted global health and economy …